Literature DB >> 31857369

Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia.

Florentien E M In 't Hout1, Mylène Gerritsen2, Lars Bullinger3, Bert A van der Reijden1, Gerwin Huls2, Edo Vellenga2, Joop H Jansen4.   

Abstract

Keywords:  Acute Myeloid Leukemia; RUNX1; TCF4

Year:  2019        PMID： 31857369      PMCID： PMC7556620          DOI： 10.3324/haematol.2019.232827

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Michele Ceribelli; Zhiying Esther Hou; Priscilla N Kelly; Da Wei Huang; George Wright; Karthik Ganapathi; Moses O Evbuomwan; Stefania Pittaluga; Arthur L Shaffer; Guido Marcucci; Stephen J Forman; Wenming Xiao; Rajarshi Guha; Xiaohu Zhang; Marc Ferrer; Laurence Chaperot; Joel Plumas; Elaine S Jaffe; Craig J Thomas; Boris Reizis; Louis M Staudt
Journal:  Cancer Cell       Date:  2016-11-14       Impact factor: 31.743

2.  TCF4 promotes erythroid development.

Authors:  Florentien E M In 't Hout; Jolanda van Duren; Davide Monteferrario; Emma Brinkhuis; Niccolo Mariani; Theresia M Westers; Dana Chitu; Gorica Nikoloski; Arjan A van de Loosdrecht; Bert A van der Reijden; Joop H Jansen; Gerwin Huls
Journal:  Exp Hematol       Date:  2018-10-10       Impact factor: 3.084

3.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

4.  RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.

Authors:  Jason H Mendler; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Heiko Becker; Klaus H Metzeler; Sebastian Schwind; Susan P Whitman; Jihane Khalife; Jessica Kohlschmidt; Deedra Nicolet; Bayard L Powell; Thomas H Carter; Meir Wetzler; Joseph O Moore; Jonathan E Kolitz; Maria R Baer; Andrew J Carroll; Richard A Larson; Michael A Caligiuri; Guido Marcucci; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2012-07-02       Impact factor: 44.544

5.  Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

Authors:  Lars Bullinger; Konstanze Döhner; Eric Bair; Stefan Fröhling; Richard F Schlenk; Robert Tibshirani; Hartmut Döhner; Jonathan R Pollack
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

6.  RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs.

Authors:  Mylène Gerritsen; Guoqiang Yi; Esther Tijchon; Jorren Kuster; Jan Jacob Schuringa; Joost H A Martens; Edo Vellenga
Journal:  Blood Adv       Date:  2019-02-12

7.  Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.

Authors:  Margherita Ghisi; Lev Kats; Frederick Masson; Jason Li; Tobias Kratina; Eva Vidacs; Omer Gilan; Maria A Doyle; Andrea Newbold; Jessica E Bolden; Kirsten A Fairfax; Carolyn A de Graaf; Matthew Firth; Johannes Zuber; Ross A Dickins; Lynn M Corcoran; Mark A Dawson; Gabrielle T Belz; Ricky W Johnstone
Journal:  Cancer Cell       Date:  2016-06-30       Impact factor: 31.743

8.  MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.

Authors:  S J Horton; J Jaques; C Woolthuis; J van Dijk; M Mesuraca; G Huls; G Morrone; E Vellenga; J J Schuringa
Journal:  Leukemia       Date:  2012-11-26       Impact factor: 11.528

9.  Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemias.

Authors:  Brynn T Kvinlaug; Wai-In Chan; Lars Bullinger; Mukundhan Ramaswami; Christopher Sears; Donna Foster; Stanley E Lazic; Rachel Okabe; Axel Benner; Benjamin H Lee; Inusha De Silva; Peter J M Valk; Ruud Delwel; Scott A Armstrong; Hartmut Döhner; D Gary Gilliland; Brian J P Huntly
Journal:  Cancer Res       Date:  2011-04-19       Impact factor: 12.701

10.  Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis.

Authors:  Na Liu; Junhong Song; Yangyang Xie; Xiao-Lin Wang; Bowen Rong; Na Man; Meng-Meng Zhang; Qunling Zhang; Fei-Fei Gao; Mei-Rong Du; Ying Zhang; Jian Shen; Chun-Hui Xu; Cheng-Long Hu; Ji-Chuan Wu; Ping Liu; Yuan-Liang Zhang; Yin-Yin Xie; Ping Liu; Jin-Yan Huang; Qiu-Hua Huang; Fei Lan; Shuhong Shen; Stephen D Nimer; Zhu Chen; Sai-Juan Chen; Robert G Roeder; Lan Wang; Xiao-Jian Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-28       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.